Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 4Phase 1 3Phase 2/3 2Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Other solid neoplasm 1

Conditions

Stomach Neoplasms 1Patients With Advanced or Metastatic Solid Tumors 1Esophageal Neoplasms 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × tegafur-gimeracil-oteracil × Clear all
NCT05396326 2022-05-31

A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Shanghai Zhongshan Hospital

Phase 1 Unknown
20 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02347904 2019-11-18

SOX

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1 Completed
40 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02867397 2016-08-15

Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors

Disphar International B.V.

Phase 1 Completed
25 enrolled
Other solid neoplasm

Patients With Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡